Clinical Trial Results: Study to Understand Risk and Resilience Opportunity for Newborns After Delivery [NA]

View source ↗

Summary

A completed clinical trial assessing risk and resilience in newborns, with a longitudinal cohort and a randomized intervention (PERCCS). Results posted in 2026.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Newborn Health
• Perinatal Outcomes

Drugs mentioned

• PERCCS

Snippet

Sponsor: Washington University School of Medicine | Conditions: A. Longitudinal Cohort n=400, B. Lower Risk (n=45) and Higher Risk (n=105) Randomized 2:1 to PERCCS Intervention | NA | Status: COMPLETED | Results posted: 2026-06-15